236 related articles for article (PubMed ID: 21190443)
1. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
[TBL] [Abstract][Full Text] [Related]
2. Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism.
Gozu HI; Lublinghoff J; Bircan R; Paschke R
Mol Cell Endocrinol; 2010 Jun; 322(1-2):125-34. PubMed ID: 20138963
[TBL] [Abstract][Full Text] [Related]
3. A new silent germline mutation of the TSH receptor: coexpression in a hyperthyroid family member with a second activating somatic mutation.
Gozu HI; Mueller S; Bircan R; Krohn K; Ekinci G; Yavuzer D; Sargin H; Sargin M; Ones T; Gezen C; Orbay E; Cirakoglu B; Paschke R
Thyroid; 2008 May; 18(5):499-508. PubMed ID: 18466076
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
Führer D; Wonerow P; Willgerodt H; Paschke R
J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
[TBL] [Abstract][Full Text] [Related]
6. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro.
Mueller S; Jaeschke H; Paschke R
Methods Enzymol; 2010; 485():421-36. PubMed ID: 21050930
[TBL] [Abstract][Full Text] [Related]
7. The extracellular thyrotropin receptor domain is not a major candidate for mutations in toxic thyroid nodules.
Führer D; Kubisch C; Scheibler U; Lamesch P; Krohn K; Paschke R
Thyroid; 1998 Nov; 8(11):997-1001. PubMed ID: 9848712
[TBL] [Abstract][Full Text] [Related]
8. Lack of consistent association of thyrotropin receptor mutations in vitro activity with the clinical course of patients with sporadic non-autoimmune hyperthyroidism.
Lueblinghoff J; Mueller S; Sontheimer J; Paschke R
J Endocrinol Invest; 2010 Apr; 33(4):228-33. PubMed ID: 19636218
[TBL] [Abstract][Full Text] [Related]
9. Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene.
Aycan Z; Ağladıoğlu SY; Ceylaner S; Cetinkaya S; Baş VN; Kendirici HN
J Clin Res Pediatr Endocrinol; 2010; 2(4):168-72. PubMed ID: 21274318
[TBL] [Abstract][Full Text] [Related]
10. Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy.
Bertalan R; Sallai A; Sólyom J; Lotz G; Szabó I; Kovács B; Szabó E; Patócs A; Rácz K
Thyroid; 2010 Mar; 20(3):327-32. PubMed ID: 20146656
[TBL] [Abstract][Full Text] [Related]
11. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor.
Grüters A; Schöneberg T; Biebermann H; Krude H; Krohn HP; Dralle H; Gudermann T
J Clin Endocrinol Metab; 1998 May; 83(5):1431-6. PubMed ID: 9589634
[TBL] [Abstract][Full Text] [Related]
12. Cases of borderline in vitro constitutive thyrotropin receptor activity: how to decide whether a thyrotropin receptor mutation is constitutively active or not?
Mueller S; Gozu HI; Bircan R; Jaeschke H; Eszlinger M; Lueblinghoff J; Krohn K; Paschke R
Thyroid; 2009 Jul; 19(7):765-73. PubMed ID: 19583488
[TBL] [Abstract][Full Text] [Related]
13. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey.
Gozu HI; Bircan R; Krohn K; Müller S; Vural S; Gezen C; Sargin H; Yavuzer D; Sargin M; Cirakoglu B; Paschke R
Eur J Endocrinol; 2006 Oct; 155(4):535-45. PubMed ID: 16990652
[TBL] [Abstract][Full Text] [Related]
14. Sporadic congenital hyperthyroidism due to a germline mutation in the thyrotropin receptor gene (Leu 512 Gln) in a Japanese patient.
Nishihara E; Fukata S; Hishinuma A; Kudo T; Ohye H; Ito M; Kubota S; Amino N; Kuma K; Miyauchi A
Endocr J; 2006 Dec; 53(6):735-40. PubMed ID: 16960398
[TBL] [Abstract][Full Text] [Related]
15. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
Paschke R
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
[TBL] [Abstract][Full Text] [Related]
16. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
[TBL] [Abstract][Full Text] [Related]
17. Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene.
Holzapfel HP; Wonerow P; von Petrykowski W; Henschen M; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Nov; 82(11):3879-84. PubMed ID: 9360555
[TBL] [Abstract][Full Text] [Related]
18. Sporadic congenital nonautoimmune hyperthyroidism caused by P639S mutation in thyrotropin receptor gene.
Agretti P; De Marco G; Biagioni M; Iannilli A; Marigliano M; Pinchera A; Vitti P; Cherubini V; Tonacchera M
Eur J Pediatr; 2012 Jul; 171(7):1133-7. PubMed ID: 22371259
[TBL] [Abstract][Full Text] [Related]
19. Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism.
Claus M; Maier J; Paschke R; Kujat C; Stumvoll M; Führer D
Thyroid; 2005 Sep; 15(9):1089-94. PubMed ID: 16187920
[TBL] [Abstract][Full Text] [Related]
20. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
Holzapfel HP; Bergner B; Wonerow P; Paschke R
Eur J Endocrinol; 2002 Jul; 147(1):109-16. PubMed ID: 12088927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
